跳至主要内容
临床试验/CTRI/2022/08/044883
CTRI/2022/08/044883已完成未知

A Double Blind, Single Centric, Randomized Placebo-Controlled Study to Demonstrate The Efficacy And Tolerability Of An Oral Treatment In The Management Of Oedema In Acute Tibio-Peroneal-Talar Sprain In Comparison To Placebo.

International Health Science Srl0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Adult male or female subjects (age 30-50 yrs).
  • 2. Adult subjects with acute ankle sprain (grade I or II)
  • 3. Able to communicate adequately with the investigator and
  • to comply with the requirements for the entire study
  • 4. Patient should be able to give written informed consent prior to
  • participating in the study

排除标准

  • 1. Steroidal anti-inflammatory drugs, NSAIDs.
  • 2. Hypersensitivity to any components of the investigational dietary
  • supplement.
  • 3. Fractures (ankle and joints) diagnosed at RX.
  • 4. Grade 3 sprain (near total loss of function, positive anterior drawer
  • and talus tilt tests, extensive bruising / haemorrhage, great insertional
  • pain, joint limitation > 10 °, edema > 2.0 cm).
  • 5. Concomitant diseases (i.e. cancer, kidney diseases, liver diseases,
  • neurological diseases, psychiatric diseases, blood disorders,
  • gastrointestinal diseases).
  • 6. Treatment with anticoagulants and Diuretics.
  • 7. Pregnancy and breastfeeding women.
  • 8. Participation in concomitant interventional clinical study or during
  • the previous 30 days.

研究者

发起方
International Health Science Srl

相似试验